152 related articles for article (PubMed ID: 37848343)
1. Potential diagnostic value of multiple indicators combined with total prostate-specific antigen in prostate cancer.
Zhang Q; Li H; Song Z; Kong S; Zhao S; Fan S; Qin F; Ma J
J Int Med Res; 2023 Oct; 51(10):3000605231204429. PubMed ID: 37848343
[TBL] [Abstract][Full Text] [Related]
2. Value of serum free prostate-specific antigen density in the diagnosis of prostate cancer.
Zou BZ; Wen H; Luo HJ; Luo WC; Xie QT; Zhou MT
Ir J Med Sci; 2023 Dec; 192(6):2681-2687. PubMed ID: 37414978
[TBL] [Abstract][Full Text] [Related]
3. The influence of prostate volume on clinical parameters in prostate cancer screening.
Shan J; Geng X; Lu Y; Liu Z; Zhu H; Zhou R; Zhang Z; Gang X; Zhang D; Shi H
J Clin Lab Anal; 2022 Oct; 36(10):e24700. PubMed ID: 36098911
[TBL] [Abstract][Full Text] [Related]
4. The influence of age on prostate cancer screening index.
Shan J; Liu Z; Geng X; Feng Y; Yang X; Xu H; Zhou X; Ma W; Zhu H; Shi H
J Clin Lab Anal; 2022 Jan; 36(1):e24098. PubMed ID: 34816496
[TBL] [Abstract][Full Text] [Related]
5. The ratio of prostate-specific antigen (PSA) to prostate volume (PSA density) as a parameter to improve the detection of prostate carcinoma in PSA values in the range of < 4 ng/mL.
Stephan C; Stroebel G; Heinau M; Lenz A; Roemer A; Lein M; Schnorr D; Loening SA; Jung K
Cancer; 2005 Sep; 104(5):993-1003. PubMed ID: 16007682
[TBL] [Abstract][Full Text] [Related]
6. Significant Diagnostic Value of Free-Serum PSA (FPSA)/Prostate-Specific Antigen Density (PSAD) and (F/T)/PSAD for Prostate Cancer of the Chinese Population in a Single Institution.
Nan LB; Yin XT; Gao JP
Med Sci Monit; 2019 Nov; 25():8345-8351. PubMed ID: 31691648
[TBL] [Abstract][Full Text] [Related]
7. [Significance of prostate central gland/total gland volume ratio combined with PSA in the diagnosis of prostate cancer patients].
Guo ZF; Lu XW; Yang F; Wu JW; Wang H; He C
Zhonghua Yi Xue Za Zhi; 2019 Sep; 99(36):2836-2839. PubMed ID: 31550812
[No Abstract] [Full Text] [Related]
8. Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting.
Guazzoni G; Nava L; Lazzeri M; Scattoni V; Lughezzani G; Maccagnano C; Dorigatti F; Ceriotti F; Pontillo M; Bini V; Freschi M; Montorsi F; Rigatti P
Eur Urol; 2011 Aug; 60(2):214-22. PubMed ID: 21482022
[TBL] [Abstract][Full Text] [Related]
9. Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: results of the prospective multicenter European trial.
Djavan B; Remzi M; Zlotta AR; Ravery V; Hammerer P; Reissigl A; Dobronski P; Kaisary A; Marberger M
Urology; 2002 Oct; 60(4 Suppl 1):4-9. PubMed ID: 12384156
[TBL] [Abstract][Full Text] [Related]
10. Significance of the prostate central gland and total gland volume ratio in the diagnosis of prostate cancer patients in the prostate specific antigen grey zone.
Guo ZF; Yang F; Lu XW; Wu JW; He C; Han CH
J Int Med Res; 2021 Jul; 49(7):3000605211019879. PubMed ID: 34308690
[TBL] [Abstract][Full Text] [Related]
11. Relationships between total/free prostate-specific antigen and prostate volume in Chinese men with biopsy-proven benign prostatic hyperplasia.
Mao Q; Zheng X; Jia X; Wang Y; Qin J; Yang K; Bai Y; Xie L
Int Urol Nephrol; 2009 Dec; 41(4):761-6. PubMed ID: 19224388
[TBL] [Abstract][Full Text] [Related]
12. Percentage of free serum prostate-specific antigen: a new tool in the early diagnosis of prostatic cancer.
Toubert ME; Guillet J; Chiron M; Meria P; Role C; Schlageter MH; Francois H; Borschneck C; Nivelon F; Desgrandchamps F; Rastel D; Cussenot O; Teillac P; Le Duc A; Najean Y
Eur J Cancer; 1996 Nov; 32A(12):2088-93. PubMed ID: 9014750
[TBL] [Abstract][Full Text] [Related]
13. Clinical research analysis based on prostate cancer screening diagnosis.
Shan J; Geng X; Liu Z; Lu Y; Zhou R; Zhang Z; Xu H; Zhou X; Ma W; Zhu H; Shi H
Andrologia; 2022 May; 54(4):e14371. PubMed ID: 35014705
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic approach to prostate cancer using total prostate specific antigen-based parameters together.
Serdar MA; Oguz O; Olgun A; Seçkin B; Ilgan S; Hasimi A; Salih M; Peker F; Kutluay T
Ann Clin Lab Sci; 2002; 32(1):22-30. PubMed ID: 11848613
[TBL] [Abstract][Full Text] [Related]
15. Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml.
Haese A; Graefen M; Steuber T; Becker C; Pettersson K; Piironen T; Noldus J; Huland H; Lilja H
Prostate; 2001 Oct; 49(2):101-9. PubMed ID: 11582588
[TBL] [Abstract][Full Text] [Related]
16. A new model consists of intravesical prostatic protrusion, prostate volume and serum prostatic-specific antigen in the evaluation of prostate cancer.
Xu D; Yu Y; Zhu Y; Huang T; Chen Y; Qi J
Pathol Oncol Res; 2014 Apr; 20(2):439-43. PubMed ID: 24178678
[TBL] [Abstract][Full Text] [Related]
17. Limited usefulness of the free-to-total prostate-specific antigen ratio for the diagnosis and staging of prostate cancer in Japanese men.
Sakai I; Harada K; Hara I; Eto H; Miyake H
Int J Clin Oncol; 2004 Feb; 9(1):64-7. PubMed ID: 15162829
[TBL] [Abstract][Full Text] [Related]
18. Contemporary use of complexed PSA and calculated percent free PSA for early detection of prostate cancer: impact of changing disease demographics.
Miller MC; O'Dowd GJ; Partin AW; Veltri RW
Urology; 2001 Jun; 57(6):1105-11. PubMed ID: 11377319
[TBL] [Abstract][Full Text] [Related]
19. The significance of TPSA, free to total PSA ratio and PSA density in prostate carcinoma diagnostics.
Milkovic B; Hadzi-Djokic J; Dzamic Z; Pejcic T
Acta Chir Iugosl; 2007; 54(4):105-7. PubMed ID: 18595240
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of various prostate specific antigen ratios for the early detection of prostate cancer.
Ozdal OL; Aprikian AG; Bégin LR; Behlouli H; Tanguay S
BJU Int; 2004 May; 93(7):970-4; discussion 974. PubMed ID: 15142145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
